 |
The global oncology precision medicine market was valued at $45,174.2 million in 2020 and is expected to reach $1,28,891.6 million by 2031, growing at..
|
 |
The global precision medicine market is expected to be $141.7 billion by 2026. The market growth is attributed to the adoption of early stage treatmen..
|
 |
The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% duri..
|
 |
The Europe infectious disease diagnostics market was valued at $1,394.3 million in 2020 and is expected to reach $7,900.4 million by 2031, witnessing ..
|
 |
The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a compound a..
|
 |
The lung cancer genomic testing market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of ..
|
 |
The global big data in healthcare market was valued at $32,925.1 million in 2021 and is expected to reach $130,132.1 million by the end of 2031. The m..
|
 |
The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 m..
|
 |
The Middle East precision medicine market was estimated to be at $3,942.6 million in 2021, which is expected to grow with a CAGR of 7.37% and reach $8..
|
 |
The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $..
|
|
|
first
prev
Profile
Writing
Friends
Share This